102 related articles for article (PubMed ID: 28776184)
1. Impact of SIGN guideline thresholds for DXA access for patients referred to direct access DXA: implications for clinical practice?
Wilson C; Loughrey PB; Cummings B; McNally C; Lindsay JR
Osteoporos Int; 2017 Nov; 28(11):3281-3282. PubMed ID: 28776184
[No Abstract] [Full Text] [Related]
2. [What clinical guideline should we use for the management of osteoporosis?].
Roig Vilaseca D; Gómez Vaquero C
Med Clin (Barc); 2011 Mar; 136(7):293-4. PubMed ID: 21185040
[No Abstract] [Full Text] [Related]
3. Dual-energy X-ray absorptiometry in clinical practice: new guidelines and concerns.
Tanner SB
Curr Opin Rheumatol; 2011 Jul; 23(4):385-8. PubMed ID: 21637082
[TBL] [Abstract][Full Text] [Related]
4. Targeted assessment of fracture risk in women at midlife.
Davis SR; Tan A; Bell RJ
Osteoporos Int; 2015 Jun; 26(6):1705-12. PubMed ID: 25630574
[TBL] [Abstract][Full Text] [Related]
5. Screening for osteoporosis: U.S. Preventive Services Task Force recommendation statement.
Nordin C
Ann Intern Med; 2011 Aug; 155(4):276; author reply 276-7. PubMed ID: 21844561
[No Abstract] [Full Text] [Related]
6. Underuse and Overuse of Osteoporosis Screening in a Regional Health System: a Retrospective Cohort Study.
Amarnath AL; Franks P; Robbins JA; Xing G; Fenton JJ
J Gen Intern Med; 2015 Dec; 30(12):1733-40. PubMed ID: 25986135
[TBL] [Abstract][Full Text] [Related]
7. Screening for osteoporosis: U.S. Preventive Services Task Force recommendation statement.
Pfister AK; Welch CW; Emmett M
Ann Intern Med; 2011 Aug; 155(4):275-6; author reply 276-7. PubMed ID: 21844559
[No Abstract] [Full Text] [Related]
8. Multidisciplinary Portuguese recommendations on DXA request and indication to treat in the prevention of fragility fractures.
Marques A; Rodrigues AM; Romeu JC; Ruano A; Barbosa AP; Simões E; Águas F; Canhão H; Alves JD; Lucas R; Branco JC; Laíns J; Mascarenhas M; Simões S; Tavares V; Lourenço O; da Silva JA
Acta Reumatol Port; 2016; 41(4):305-321. PubMed ID: 27750276
[TBL] [Abstract][Full Text] [Related]
9. Adherence and efficacy of screening for low bone mineral density among ulcerative colitis patients treated with corticosteroids.
Khan N; Abbas AM; Almukhtar RM; Cole EB; Khan AN
Am J Gastroenterol; 2014 Apr; 109(4):572-8. PubMed ID: 24469613
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostics, risk and indication for treatment of osteoporosis].
Kindmark A; Salminen H
Lakartidningen; 2016 Nov; 113():. PubMed ID: 27824392
[No Abstract] [Full Text] [Related]
11. Does insufficient access to dual-energy X-ray absorptiometry (DXA) stifle the provision of quality osteoporosis care in New Zealand?
Milsom S; Leung W; Twigden V; Mitchell P; Nowitz M; Cornish J
Arch Osteoporos; 2013; 8():120. PubMed ID: 23361437
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.
Ito K; Leslie WD
Osteoporos Int; 2015 Aug; 26(8):2111-9. PubMed ID: 25807913
[TBL] [Abstract][Full Text] [Related]
13. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].
Naranjo A; Ojeda-Bruno S; Francisco-Hernández F; Erausquin C; Rúa-Figueroa I; Rodríguez-Lozano C
Med Clin (Barc); 2011 Mar; 136(7):290-2. PubMed ID: 21185575
[TBL] [Abstract][Full Text] [Related]
14. Worldwide Fracture Prediction.
El-Hajj Fuleihan G; Chakhtoura M; Cauley JA; Chamoun N
J Clin Densitom; 2017; 20(3):397-424. PubMed ID: 28734709
[TBL] [Abstract][Full Text] [Related]
15. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
[TBL] [Abstract][Full Text] [Related]
16. Screening for Osteoporosis to Prevent Fractures.
Jin J
JAMA; 2018 Jun; 319(24):2566. PubMed ID: 29946730
[No Abstract] [Full Text] [Related]
17. Bone health management in men undergoing ADT: examining enablers and barriers to care.
Damji AN; Bies K; Alibhai SM; Jones JM
Osteoporos Int; 2015 Mar; 26(3):951-9. PubMed ID: 25526712
[TBL] [Abstract][Full Text] [Related]
18. [Swiss guidance for the diagnosis and management of osteoporosis].
Kraenzlin ME
Rev Med Suisse; 2013 Jun; 9(390):1272, 1274-8. PubMed ID: 23821846
[TBL] [Abstract][Full Text] [Related]
19. [Use of Trabecular Bone Score as a complementary approach to DXA for fracture risk assessment in clinical practice].
Hans D; Shevroja E; Lamy O
Rev Med Suisse; 2017 Apr; 13(559):844-850. PubMed ID: 28727341
[TBL] [Abstract][Full Text] [Related]
20. The effects of a patient activation intervention on smoking and excessive drinking cessations: results from the PAADRN randomized controlled trial.
Wolinsky FD; Lou Y; Edmonds SW; Saag KG; Roblin DW; Wright NC; Jones MP; Cram P;
Osteoporos Int; 2017 Oct; 28(10):3055-3060. PubMed ID: 28573377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
